Biologics Safety Testing Market
                     Biologics Safety Testing Market
Global Forecast to 2029
Biologics Safety Testing 
Market is expected to reach 
USD 7.2 billion by 2029 
 Growing at a 
CAGR of  11.1% (2024 – 2029)
SINGLE USE BIOPROCESSING MARKET 
MARKET 
CAGR of OPPORTUNITY OVER KEY MARKET PLAYERS BY TEST TYPE 
2024 – 2029 NEXT 5 YEARS
$7.2Bn 
CAGR Thermo Fisher Scientific Inc. (US)$4.2  Mycoplasma Tests Merck KGaA (Germany)
Bn
  Lonza (Switzerland) Sterility Tests
  FUJIFILM Corporation (Japan) Endotoxin Tests
  Sartorius AG (Germany) Virus Safety Tests
2024 2029
  F. Hoffmann-La Roche Ltd (Switzerland)
BY REGION BY END USER
• North America Pharmaceutical & 
• Europe Biotechnology 
• Asia Pacific Companies
• Rest of the World CROs and CDMOs
Academic and 
Research Institutes
The size of global biologics safety testing market in terms of revenue was estimated 
to be worth $4.2 billion in 2024 and is poised to reach $7.2 billion by 2029, growing at 
a CAGR of 11.1% from 2024 to 2029. The new research study consists of an industry 
trend analysis of the market. The new research study consists of industry trends, 
pricing analysis, patent analysis, conference and webinar materials, key stakeholders, 
and buying behaviour in the market.
Growth of the market can be attributed to factors such as the rising need for novel 
biotherapeutics and increasing focus on advancement of biopharmaceutical industry. 
However, ethical concern about animal testing may hamper the growth of the market.
Download PDF Brochure:
The Biologics Safety Testing Market is dominated by players such as 
• Thermo Fisher Scientific Inc. (US)
•  Merck KGaA (Germany)
•  Lonza (Switzerland)
•  FUJIFILM Corporation (Japan)
•  Sartorius AG (Germany)
•  F. Hoffmann-La Roche Ltd (Switzerland)
•  Charles River Laboratories (US)
•  BIOMÉRIEUX (France)
•  Maravai LifeSciences (US)
•  WuXi AppTec (China)
  
North America dominated the biologics safety testing industry in 2023.
The global biologics safety testing market is segmented into six major regions—North 
America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. North 
America accounted for the largest share of market in 2023, followed by Europe and 
the Asia Pacific. Factors such as significant expenditure on R&D activities, presence of 
a well-established healthcare market, growing need of advanced therapies are 
responsible for the largest share of North America region in market.
Request Sample Pages
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
UK +44-800-368-9399
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/